Literature DB >> 17139035

Influence of sub-syndromal symptoms after remission from manic or mixed episodes.

Mauricio Tohen1, Charles L Bowden, Joseph R Calabrese, Daniel Lin, Tammy D Forrester, Gary S Sachs, Athanasios Koukopoulos, Lakshmi Yatham, Heinz Grunze.   

Abstract

BACKGROUND: Sub-syndromal symptoms in bipolar disorder impair functioning and diminish quality of life. AIMS: To examine factors associated with time spent with sub-syndromal symptoms and to characterise how these symptoms influence outcomes.
METHOD: In a double-blind randomised maintenance trial, patients received either olanzapine or lithium monotherapy for 1 year. Stepwise logistic regression models were used to identify factors that were significant predictors of percentage time spent with sub-syndromal symptoms. The presence of sub-syndromal symptoms during the first 8 weeks was examined as a predictor of subsequent relapse.
RESULTS: Presence of sub-syndromal depressive symptoms during the first 8 weeks significantly increased the likelihood of depressive relapse (relative risk 4.67, P<0.001). Patients with psychotic features and those with a greater number of previous depressive episodes were more likely to experience sub-syndromal depressive symptoms (RR=2.51, P<0.001 and RR=2.35, P=0.03 respectively).
CONCLUSIONS: These findings help to identify patients at increased risk of affective relapse and suggest that appropriate therapeutic interventions should be considered even when syndromal-level symptoms are absent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139035     DOI: 10.1192/bjp.bp.105.020321

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  The Turkish Adaptation, Validity, and Reliability of the Internal States Scale.

Authors:  Zeynep Maçkali; Cengiz Akkaya; Ömer Aydemir
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

2.  Olfactory acuity is associated with mood and function in a pilot study of stable bipolar disorder patients.

Authors:  Caitlin Hardy; Mary Rosedale; Julie W Messinger; Karine Kleinhaus; Nicole Aujero; Hanna Silva; Raymond R Goetz; Deborah Goetz; Jill Harkavy-Friedman; Dolores Malaspina
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

3.  Development of the Bipolar Inventory of Symptoms Scale: concurrent validity, discriminant validity and retest reliability.

Authors:  Jodi M Gonzalez; Charles L Bowden; Martin M Katz; Peter Thompson; Vivek Singh; Thomas J Prihoda; Martha Dahl
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

4.  Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder.

Authors:  Gianluca Serafini; Gustavo H Vazquez; Xenia Gonda; Maurizio Pompili; Zoltan Rihmer; Mario Amore
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-07       Impact factor: 5.270

5.  Social-cognitive bias and depressive symptoms in outpatients with bipolar disorder.

Authors:  Guillermo Lahera; Adolfo Benito; Ana González-Barroso; Rocío Guardiola; Sara Herrera; Beatriz Muchada; Noelia Cojedor; Alberto Fernández-Liria
Journal:  Depress Res Treat       Date:  2012-01-23

6.  Mindfulness-based cognitive therapy versus psychoeducational intervention in bipolar outpatients with sub-threshold depressive symptoms: a randomized controlled trial.

Authors:  Guillermo Lahera; Carmen Bayón; Maria Fe Bravo-Ortiz; Beatriz Rodríguez-Vega; Sara Barbeito; Margarita Sáenz; Caridad Avedillo; Rosa Villanueva; Amaia Ugarte; Ana González-Pinto; Consuelo de Dios
Journal:  BMC Psychiatry       Date:  2014-08-15       Impact factor: 3.630

7.  [Factors predicting functioning in type 1 bipolar patients during remission period].

Authors:  Feten Fekih-Romdhane; Wided Homri; Ali Mrabet; Raja Labbane
Journal:  Pan Afr Med J       Date:  2016-10-03

8.  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.

Authors:  Konstantinos N Fountoulakis; Lakshmi N Yatham; Heinz Grunze; Eduard Vieta; Allan H Young; Pierre Blier; Mauricio Tohen; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-23       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.